Top Story

Corrona: Leveraging 'Big Data' for Improved Patient Outcomes

Corrona: Leveraging 'Big Data' for Improved Patient Outcomes
July 19, 2019
In the JournalsPerspective

Peripheral arthritis can occur at any time during new axial SpA

July 3, 2019
Among patients with recent-onset axial spondyloarthritis, 36% reported developing peripheral arthritis at any time during their disease duration, with these patients…
In the JournalsPerspective

Opioid prescription common in patients with ankylosing spondylitis

June 26, 2019
Opioid use is highly prevalent among patients with ankylosing spondylitis, ranging from 23.5% in patients with commercial insurance using the ICD code of 720.0, to 76%…
In the Journals

Less than half of patients with AS remain on first TNF inhibitor after 5 years

June 25, 2019
Only 46% of patients with ankylosing spondylitis remain on their first TNF inhibitor after 5 years, with one-third ending up with no anti-rheumatic treatment after this…
More Headlines »

Inflammatory Eye Disorders: Diagnosis, Treatment, and Referral

This activity is supported by an educational grant from AbbVie, Inc.

Underlying conditions leading to ocular tissue inflammation can be challenging to diagnose, treat, and effectively…
More »
Meeting News

VIDEO: HLA alleles may predict development of sacroiliitis in PsA

December 4, 2017
More »

Highlights of the Rheumatology Summit: A Master Class in RA, PsA, and SpA

This activity is supported by independent educational grants from AbbVie; Celgene Corporation; Lilly USA, LLC; Merck & Co., Inc.; and Pfizer, Inc.

This CME-certified monograph is specifically designed for health care professionals to advance their knowledge…
More »